NTRK1 and acute myeloid leukemia: In AML it has been shown that highly frequent mutations to the receptor tyrosine kinase FLT3 (internal tandem duplication; ITD and tyrosine kinase domain; TKD) increase Y654 phosphorylation of β-catenin leading to its enhanced abundance and activity in the nucleus [78–80].